Subtenons anaesthesia more comfortable for photophobics

Article

Patients who report photophobia prior to phacoemulsification may be more comfortable under subtenon anaesthesia.

Patients who report photophobia prior to phacoemulsification may be more comfortable under subtenon anaesthesia, according to Alexander Ioannidis and colleagues from the Mid-Essex Hospitals NHS Trust, London, UK.

Forty-nine patients were randomized to receive either 0.5 ml preservative free 1% intracameral lidocaine or 4 ml of 2% lidocaine subtenons anaesthesia. Each subject was assessed by slit-lamp with maximal pupillary dilation on the day of surgery. Eyes were exposed to 10 seconds of light from a broad beam and a visual analogue scale was used to assess pain and photophobia.

In the topical group, the average postoperative pain score was 1.00 and the average postoperative photophobia score was 1.18. In the subtenons group, the average pain score was 0.83 and the average photophobia score was 1.12.

It was concluded that subtenons anaesthesia may be more suitable for patients who experience photophobia preoperatively.

Recent Videos
Patrick C. Staropoli, MD, discusses clinical characterisation of Hexokinase 1 (HK1) mutations causing autosomal dominant pericentral retinitis pigmentosa
Richard B. Rosen, MD, discusses his ASRS presentation on illuminating subclinical sickle cell activities using dynamic OCT angiography
ASRS 2024: Socioeconomic barriers and visual outcomes in patients with rhegmatogenous retinal detachments, from Sally S. Ong, MD
Ashkan Abbey, MD, speaks about his presentation on the the CALM registry study, the 36-month outcomes of real world patients receiving fluocinolone acetonide 0.18 mg at the annual ASRS meeting in Stockholm, Sweden.
Nikoloz Labauri, MD, FVRS, speaks at the 2024 ASRS meeting about suspensory macular buckling as a novel technique for addressing myopic traction maculopathy
Jordana Fein, MD, MS, speaks with Modern Retina about the IOP outcomes with aflibercept 8 mg and 2 mg in patients with DME through week 48 of the phase 2/3 PHOTON trial at the annual ASRS meeting in Stockholm, Sweden.
John T. Thompson, MD, discusses his presentation at ASRS, Long-Term Results of Macular Hole Surgery With Long-Acting Gas Tamponade and Internal Limiting Membrane Peeling
ASRS 2024: Michael Singer, MD, shares 100-week results from the RESTORE trial
© 2024 MJH Life Sciences

All rights reserved.